SCHEMBL12530366

SCHEMBL12530366

ONC1CC2CCC(C1)N2Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.62
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
L3MBTL1 Q9Y468 2/20 0.58
CYP2D6 P10635 1/20 0.56
CYP2C19 P33261 1/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
LMNA P02545 1/20 0.56
LTA4H P09960 1/20 0.55
OPRK1 P41145 2/20 0.54
OPRM1 P35372 1/20 0.54
OPRD1 P41143 1/20 0.54
KCNH2 Q12809 1/20 0.54
USP2 O75604 1/20 0.53
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
CHRM5 P08912 1/20 0.53
CHRNB2 P17787 1/20 0.51
CHRNA7 P36544 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15071683 0.83 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL6536312 0.83 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL31210789 0.83 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL15071539 0.83 ALDH1A1 (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL4274767 0.83 L3MBTL1 (0.68) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL6997045 0.82 ACHE (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL6997039 0.82 ACHE (0.58) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL694189 0.81 CHRM2 (0.62) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL16766586 0.81 CHRM2 (0.62) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6
SCHEMBL16766562 0.81 CHRM2 (0.62) ALDH1A1KMT2AMEN1L3MBTL1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110160235-A1 TRIAZOLYL TROPANE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2011-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160235-A1 TRIAZOLYL TROPANE DERIVATIVES CCR5, CXCR4, CXCR3 ALDH1A1 2139/4885KMT2A 4488/4885MEN1 4492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.